CA2116341A1 - Needleless Injector - Google Patents

Needleless Injector

Info

Publication number
CA2116341A1
CA2116341A1 CA 2116341 CA2116341A CA2116341A1 CA 2116341 A1 CA2116341 A1 CA 2116341A1 CA 2116341 CA2116341 CA 2116341 CA 2116341 A CA2116341 A CA 2116341A CA 2116341 A1 CA2116341 A1 CA 2116341A1
Authority
CA
Canada
Prior art keywords
outlet orifice
needleless injector
piston
metering chamber
injector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2116341
Other languages
French (fr)
Other versions
CA2116341C (en
Inventor
Terence Edward Weston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Weston Medical Ltd
Original Assignee
Terence Edward Weston
Weston Medical Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terence Edward Weston, Weston Medical Limited filed Critical Terence Edward Weston
Publication of CA2116341A1 publication Critical patent/CA2116341A1/en
Application granted granted Critical
Publication of CA2116341C publication Critical patent/CA2116341C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/5436—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand physically entrapped within the solid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01G—HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
    • A01G7/00—Botany in general
    • A01G7/06—Treatment of growing trees or plants, e.g. for preventing decay of wood, for tingeing flowers or wood, for prolonging the life of plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M5/204—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically connected to external reservoirs for multiple refilling

Abstract

A needleless injector comprises a liquid metering chamber (31, 131) having an outlet orifice (21, 121), a piston (7, 107) slidable within the metering chamber, and a rod (6, 106) which is arranged to strike one end of the piston to force liquid through the outlet orifice. The injector is in two parts (1, 2; 101, 102) which are biassed away from one another, and the front one of which carries the outlet orifice. Actuation only occurs when one part is sufficiently urged towards the other by the user.
CA002116341A 1991-08-23 1992-08-21 Needleless injector Expired - Fee Related CA2116341C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9118204.8 1991-08-23
GB919118204A GB9118204D0 (en) 1991-08-23 1991-08-23 Needle-less injector
PCT/GB1992/001539 WO1993003779A1 (en) 1991-08-23 1992-08-21 Needleless injector

Publications (2)

Publication Number Publication Date
CA2116341A1 true CA2116341A1 (en) 1993-03-04
CA2116341C CA2116341C (en) 1999-12-14

Family

ID=10700421

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002116341A Expired - Fee Related CA2116341C (en) 1991-08-23 1992-08-21 Needleless injector

Country Status (15)

Country Link
US (1) US5480381A (en)
EP (1) EP0599940B1 (en)
JP (2) JP3257794B2 (en)
KR (1) KR100233339B1 (en)
AT (1) ATE161427T1 (en)
AU (1) AU2444592A (en)
BR (1) BR9206407A (en)
CA (1) CA2116341C (en)
DE (1) DE69223793T2 (en)
ES (1) ES2110513T3 (en)
GB (1) GB9118204D0 (en)
HK (1) HK1010993A1 (en)
NO (1) NO307817B1 (en)
RU (1) RU2129445C1 (en)
WO (1) WO1993003779A1 (en)

Families Citing this family (425)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6056716A (en) * 1987-06-08 2000-05-02 D'antonio Consultants International Inc. Hypodermic fluid dispenser
US5569190A (en) * 1987-06-08 1996-10-29 D'antonio; Nicholas F. Hypodermic fluid dispenser
TW404844B (en) 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe
CA2167586C (en) * 1993-07-31 2005-01-25 Terence Edward Weston Needle-less injector
US5599302A (en) 1995-01-09 1997-02-04 Medi-Ject Corporation Medical injection system and method, gas spring thereof and launching device using gas spring
DE29507987U1 (en) * 1995-05-15 1996-09-19 Ferton Holding Ejection device for high pressure ejection of a liquid
US6223786B1 (en) 1998-11-14 2001-05-01 Pen Jet Corporation Apparatus and method for mixing medication and filling an ampule of a needle-less injector
US5730723A (en) * 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
US6080130A (en) * 1998-11-14 2000-06-27 Castellano; Thomas P. Gas power source for a needle-less injector
US5865795A (en) 1996-02-29 1999-02-02 Medi-Ject Corporation Safety mechanism for injection devices
US5722953A (en) 1996-02-29 1998-03-03 Medi-Ject Corporation Nozzle assembly for injection device
US5697917A (en) 1996-02-29 1997-12-16 Medi-Ject Corporation Nozzle assembly with adjustable plunger travel gap
US5800388A (en) 1996-02-29 1998-09-01 Medi-Ject Corporation Plunger/ram assembly adapted for a fluid injector
US5921967A (en) 1996-02-29 1999-07-13 Medi-Ject Corporation Plunger for nozzle assembly
US5769138A (en) * 1996-04-01 1998-06-23 Medi-Ject Corporation Nozzle and adapter for loading medicament into an injector
GB9607549D0 (en) * 1996-04-11 1996-06-12 Weston Medical Ltd Spring-powered dispensing device
JP3624543B2 (en) * 1996-05-02 2005-03-02 東ソー株式会社 Immune reaction reagent and method for producing the same
ATE252398T1 (en) 1996-07-01 2003-11-15 Pharmacia Ab DISPENSING DEVICE AND OPERATING METHOD THEREOF
FR2751228B1 (en) * 1996-07-19 1998-11-20 Rhone Merieux BOVINE POLYNUCLEOTIDE VACCINE FOR INTRADERMAL ROUTE
AU4705797A (en) * 1996-09-26 1998-04-17 Akzo Nobel N.V. Needle-less injector
WO1998013087A2 (en) 1996-09-27 1998-04-02 Weston Medical Limited Needleless injector accessory
US5875976A (en) 1996-12-24 1999-03-02 Medi-Ject Corporation Locking mechanism for nozzle assembly
US5993412A (en) * 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
US5911703A (en) * 1997-05-22 1999-06-15 Avant Drug Delivery Systems, Inc. Two-stage fluid medicament jet injector
US6171276B1 (en) 1997-08-06 2001-01-09 Pharmacia & Upjohn Ab Automated delivery device and method for its operation
US6156008A (en) * 1998-05-04 2000-12-05 Castellano; Thomas P. Device for avoiding subdermal hematomas from an injection
WO2000006227A1 (en) * 1998-07-27 2000-02-10 Medi-Ject Corporation Loading mechanism for medical injector assembly
CN1651103A (en) 1998-07-27 2005-08-10 安塔雷斯药品公司 Injection device
US6406455B1 (en) * 1998-12-18 2002-06-18 Biovalve Technologies, Inc. Injection devices
US6689095B1 (en) * 1999-04-22 2004-02-10 Gilbert Garitano Needleless permanent makeup and tattoo device
WO2000067825A1 (en) * 1999-05-07 2000-11-16 Microheart, Inc. Apparatus and method for delivering therapeutic and diagnostic agents
US7192713B1 (en) 1999-05-18 2007-03-20 President And Fellows Of Harvard College Stabilized compounds having secondary structure motifs
WO2000072908A1 (en) * 1999-06-02 2000-12-07 Microheart, Inc. Devices and methods for delivering a drug
US7147633B2 (en) * 1999-06-02 2006-12-12 Boston Scientific Scimed, Inc. Method and apparatus for treatment of atrial fibrillation
US20020193740A1 (en) 1999-10-14 2002-12-19 Alchas Paul G. Method of intradermally injecting substances
US6569143B2 (en) 1999-10-14 2003-05-27 Becton, Dickinson And Company Method of intradermally injecting substances
US6494865B1 (en) 1999-10-14 2002-12-17 Becton Dickinson And Company Intradermal delivery device including a needle assembly
US6843781B2 (en) * 1999-10-14 2005-01-18 Becton, Dickinson And Company Intradermal needle
US6569123B2 (en) 1999-10-14 2003-05-27 Becton, Dickinson And Company Prefillable intradermal injector
US6776776B2 (en) * 1999-10-14 2004-08-17 Becton, Dickinson And Company Prefillable intradermal delivery device
WO2001051109A1 (en) * 2000-01-07 2001-07-19 Biovalve Technologies, Inc. Injection device
US6210359B1 (en) 2000-01-21 2001-04-03 Jet Medica, L.L.C. Needleless syringe
DE10010123A1 (en) 2000-03-03 2001-09-20 Boehringer Ingelheim Int Needle-less injector for liquids comprises a tensioning system, an energy storing spring, a hollow piston in a cylinder, and a nozzle
US6689092B2 (en) 2000-03-03 2004-02-10 Boehringer International Gmbh Needle-less injector of miniature type
US6406456B1 (en) 2000-06-08 2002-06-18 Avant Drug Delivery Systems, Inc. Jet injector
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
WO2002051470A2 (en) * 2000-11-30 2002-07-04 Biovalve Technologies, Inc. Injection systems
US6758837B2 (en) * 2001-02-08 2004-07-06 Pharmacia Ab Liquid delivery device and method of use thereof
WO2002074336A2 (en) 2001-02-23 2002-09-26 Glaxosmithkline Biologicals S.A. Influenza vaccine formulations for intradermal delivery
JP2004529754A (en) 2001-03-14 2004-09-30 ペンジェット・コーポレーション System and method for removing dissolved gases from a solution
ZA200200808B (en) * 2001-03-22 2002-08-12 Roche Diagnostics Gmbh Needleless hypodermic injection system, application device and medication cartridge therefor.
GB0109297D0 (en) 2001-04-12 2001-05-30 Glaxosmithkline Biolog Sa Vaccine
US6613010B2 (en) 2001-04-13 2003-09-02 Penjet Corporation Modular gas-pressured needle-less injector
US20050192530A1 (en) * 2001-04-13 2005-09-01 Penjet Corporation Method and apparatus for needle-less injection with a degassed fluid
US6755220B2 (en) 2001-04-27 2004-06-29 Penjet Corporation Method and apparatus for filling or refilling a needle-less injector
WO2002096311A1 (en) * 2001-05-30 2002-12-05 Tomoyuki Takahashi Safe laser hair removal system with a protraction-retraction mechanism
MY134424A (en) 2001-05-30 2007-12-31 Saechsisches Serumwerk Stable influenza virus preparations with low or no amount of thiomersal
US20100221284A1 (en) 2001-05-30 2010-09-02 Saech-Sisches Serumwerk Dresden Novel vaccine composition
WO2003002069A2 (en) * 2001-06-29 2003-01-09 Becton, Dickinson And Company Intradermal delivery of vaccines and gene therapeutic agents via microcannula
US20060018877A1 (en) * 2001-06-29 2006-01-26 Mikszta John A Intradermal delivery of vacccines and therapeutic agents
US8061006B2 (en) 2001-07-26 2011-11-22 Powderject Research Limited Particle cassette, method and kit therefor
US6669664B2 (en) 2001-09-07 2003-12-30 Avant Drug Delivery Systems, Inc. Vacuum control cycle for jet injector
US6824526B2 (en) 2001-10-22 2004-11-30 Penjet Corporation Engine and diffuser for use with a needle-less injector
US6939323B2 (en) 2001-10-26 2005-09-06 Massachusetts Institute Of Technology Needleless injector
CA2371466C (en) * 2002-02-12 2010-02-09 Medical International Technology (Mit) Inc. Needleless injector
DK1515763T3 (en) * 2002-06-10 2011-11-21 Intervet Int Bv Needless injector
MXPA05002072A (en) 2002-08-26 2005-06-08 Penjet Corp Apparatus for needle-less injection with a degassed fluid.
US20040106894A1 (en) * 2002-09-06 2004-06-03 Massachusetts Institute Of Technology Needleless drug injection device
DE10252917A1 (en) * 2002-11-12 2004-05-27 Lothar Bode Device used for applying substances under pressure to skin comprises main component with pressure medium container, controllable stop valve, pressure reducer and nozzle
US6939319B1 (en) * 2002-11-20 2005-09-06 Conrad Anstead Process and device for single use, needle-free intradermal, subcutaneous, or intramuscular injections
JP2006507061A (en) * 2002-11-25 2006-03-02 テクファーマ・ライセンシング・アクチェンゲゼルシャフト Automatic injection device with resettable release safety device
CN1833030B (en) 2003-05-22 2014-07-23 美国弗劳恩霍夫股份有限公司 Recombinant carrier molecule for expression, delivery and purification of target polypeptides
AU2003270473A1 (en) * 2003-09-09 2005-04-27 University Of Florida Desferrithiocin derivatives and their use as iron chelators
CA2545207A1 (en) * 2003-11-27 2005-06-09 Novo Nordisk A/S Impulse chamber for jet delivery device
EP1711217A1 (en) * 2004-01-26 2006-10-18 Novo Nordisk A/S Impulse chamber for jet delivery device
WO2005122722A2 (en) 2004-06-09 2005-12-29 D'antonio Consultants International, Inc. Hypodermic injection system
EP2181714A3 (en) 2004-09-22 2010-06-23 GlaxoSmithKline Biologicals S.A. Immunogenic composition for use in vaccination against staphylococcei
US9492400B2 (en) * 2004-11-04 2016-11-15 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
JP4904283B2 (en) * 2004-12-01 2012-03-28 アキュショット インク Needleless syringe
JP5364110B2 (en) * 2005-01-07 2013-12-11 柴田科学株式会社 Transmitted light amount measuring device, relative absorbance measuring device, and measuring methods thereof
US7833189B2 (en) 2005-02-11 2010-11-16 Massachusetts Institute Of Technology Controlled needle-free transport
US20090081253A1 (en) 2005-03-23 2009-03-26 Glaxosmithkline Biologicals S.A. Composition
MX2007012226A (en) 2005-04-04 2007-12-10 Univ Florida Desferrithiocin polyether analogues.
KR101446025B1 (en) * 2005-08-03 2014-10-01 아이바이오, 인크. Compositions and methods for production of immunoglobulins
US20070055199A1 (en) * 2005-08-10 2007-03-08 Gilbert Scott J Drug delivery device for buccal and aural applications and other areas of the body difficult to access
CA2629300C (en) 2005-11-17 2014-07-08 Zogenix, Inc. Delivery of viscous formulations by needle-free injection
TWI457133B (en) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa Novel composition
WO2007070682A2 (en) * 2005-12-15 2007-06-21 Massachusetts Institute Of Technology System for screening particles
TW201350129A (en) 2005-12-22 2013-12-16 Glaxosmithkline Biolog Sa Streptococcus pneumoniae immunogenic composition comprising capsular saccharide conjugates, vaccine and kit comprising the same and uses thereof
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
US20070185053A1 (en) * 2006-01-17 2007-08-09 Zogenix, Inc. Single-dose needle-free administration of antithrombotic medications
US20070264130A1 (en) * 2006-01-27 2007-11-15 Phluid, Inc. Infusion Pumps and Methods for Use
AU2007215082B2 (en) * 2006-02-13 2012-07-12 Ibio, Inc. HPV antigens, vaccine compositions, and related methods
KR20080106433A (en) * 2006-02-13 2008-12-05 프라운호퍼 유에스에이, 인코포레이티드 Influenza antigens, vaccine compositions, and related methods
US8277816B2 (en) * 2006-02-13 2012-10-02 Fraunhofer Usa, Inc. Bacillus anthracis antigens, vaccine compositions, and related methods
EP1998684A4 (en) * 2006-03-10 2014-09-17 Massachusetts Inst Technology Triggered self-assembly conjugates and nanosystems
US7666912B2 (en) 2006-03-23 2010-02-23 Massachusetts Eye And Ear Infirmary Compositions and methods for reducing body fat
CA2647441C (en) 2006-03-30 2021-02-23 Glaxosmithkline Biologicals S.A. Immunogenic composition comprising staphylococcus aureus saccharides
ES2776100T3 (en) 2006-03-31 2020-07-29 Massachusetts Inst Technology System for targeted delivery of therapeutic agents
US20090325944A1 (en) * 2006-04-12 2009-12-31 Suzanne Walker Kahne Methods and Compositions for Modulating Glycosylation
CN101426543A (en) * 2006-04-21 2009-05-06 诺沃-诺迪斯克有限公司 Two stage jet injection device
JP5630998B2 (en) 2006-05-15 2014-11-26 マサチューセッツ インスティテュート オブ テクノロジー Polymers for functional particles
WO2007137117A2 (en) * 2006-05-17 2007-11-29 Massachusetts Institute Of Technology Aptamer-directed drug delivery
ES2570334T3 (en) 2006-06-02 2016-05-17 Harvard College Surface protein remodeling
WO2007150030A2 (en) 2006-06-23 2007-12-27 Massachusetts Institute Of Technology Microfluidic synthesis of organic nanoparticles
DK2422810T3 (en) 2006-07-17 2014-11-24 Glaxosmithkline Biolog Sa Influenza vaccine
WO2008021367A2 (en) * 2006-08-11 2008-02-21 President And Fellows Of Harvard College Moenomycin biosynthesis-related compositions and methods of use thereof
AU2007284496A1 (en) * 2006-08-14 2008-02-21 Massachusetts Institute Of Technology Glycan data mining system
US20090269342A1 (en) * 2006-08-14 2009-10-29 Massachusetts Institute Of Technology Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
ES2773842T3 (en) * 2006-09-01 2020-07-15 Massachusetts Inst Technology Needle-free injector device with automatic loading capacity
US7942845B2 (en) * 2006-09-19 2011-05-17 Bioject, Inc. Needle-free injector and process for providing serial injections
US7547293B2 (en) 2006-10-06 2009-06-16 Bioject, Inc. Triggering mechanism for needle-free injector
JO3598B1 (en) 2006-10-10 2020-07-05 Infinity Discovery Inc Boronic acids and esters as inhibitors of fatty acid amide hydrolase
EP2433648A3 (en) 2006-10-12 2012-04-04 GlaxoSmithKline Biologicals S.A. Vaccine comprising an oil in water emulsion adjuvant
ES2397714T3 (en) 2006-10-12 2013-03-08 Glaxosmithkline Biologicals S.A. Vaccine comprising an oil-in-water emulsion adjuvant
WO2008147456A2 (en) * 2006-11-20 2008-12-04 Massachusetts Institute Of Technology Drug delivery systems using fc fragments
MX2009005727A (en) 2006-12-01 2009-08-27 Anterios Inc Amphiphilic entity nanoparticles.
WO2008073856A2 (en) * 2006-12-08 2008-06-19 Massachusetts Institute Of Technology Delivery of nanoparticles and/or agents to cells
DK2474525T3 (en) 2006-12-26 2020-07-13 Lantheus Medical Imaging Inc Ligands for imaging cardiac innervation
EP2118123B1 (en) 2007-01-31 2015-10-14 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
EP2134830A2 (en) 2007-02-09 2009-12-23 Massachusetts Institute of Technology Oscillating cell culture bioreactor
US7744563B2 (en) * 2007-02-23 2010-06-29 Bioject, Inc. Needle-free injection devices and drug delivery systems therefor
US8324397B2 (en) 2007-03-15 2012-12-04 University Of Florida Research Foundation, Inc. Desferrithiocin polyether analogues
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
JP5631201B2 (en) 2007-03-28 2014-11-26 プレジデント アンド フェローズ オブ ハーバード カレッジ Stitched polypeptide
WO2008124634A1 (en) 2007-04-04 2008-10-16 Massachusetts Institute Of Technology Polymer-encapsulated reverse micelles
JP2010523595A (en) 2007-04-04 2010-07-15 マサチューセッツ インスティテュート オブ テクノロジー Poly (amino acid) targeting part
US8778348B2 (en) * 2007-04-28 2014-07-15 Ibio Inc. Trypanosoma antigens, vaccine compositions, and related methods
PT2175881E (en) * 2007-06-14 2012-10-22 Crucell Switzerland Ag Intradermal influenza vaccine
US8524444B2 (en) 2007-06-15 2013-09-03 President And Fellows Of Harvard College Methods and compositions for detections and modulating O-glycosylation
AU2008267208B2 (en) 2007-06-26 2012-01-19 Glaxosmithkline Biologicals S.A. Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
CA2692933C (en) 2007-07-11 2016-10-18 Fraunhofer Usa, Inc. Yersinia pestis antigens, vaccine compositions, and related methods
CA2696764A1 (en) * 2007-08-20 2009-02-26 Fraunhofer Usa, Inc. Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods
EP2205074A4 (en) * 2007-10-04 2013-07-31 Harvard College Moenomycin analogs, methods of synthesis, and uses thereof
WO2009051837A2 (en) 2007-10-12 2009-04-23 Massachusetts Institute Of Technology Vaccine nanotechnology
WO2009089119A2 (en) * 2008-01-03 2009-07-16 Massachusetts Institute Of Technology Decoy influenza therapies
US8193182B2 (en) 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
US8986253B2 (en) * 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
PE20091838A1 (en) * 2008-04-09 2009-12-18 Infinity Pharmaceuticals Inc FATTY ACID AMIDA HYDROLASE INHIBITORS
CN102099052A (en) 2008-04-16 2011-06-15 葛兰素史密丝克莱恩生物有限公司 Vaccine
CN102066405B (en) * 2008-04-28 2015-09-30 哈佛大学校长及研究员协会 For the supercharged proteins of cell-penetrating
ES2604968T3 (en) 2008-04-28 2017-03-10 Zogenix, Inc. New formulations for the treatment of migraine
WO2009143188A2 (en) * 2008-05-19 2009-11-26 Diperna Paul M Disposable pump reservoir and related methods
KR100888831B1 (en) 2008-06-02 2009-03-19 (주)클래시스 Needleless jet injection device
US20110212157A1 (en) 2008-06-26 2011-09-01 Anterios, Inc. Dermal delivery
DK2318832T3 (en) 2008-07-15 2014-01-20 Academia Sinica Glycan arrays on PTFE-like aluminum coated slides and related methods
WO2010011318A2 (en) * 2008-07-23 2010-01-28 Massachusetts Institute Of Technology Activatiqn of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival
EP2356139A4 (en) 2008-07-23 2013-01-09 Harvard College Ligation of stapled polypeptides
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
US8650937B2 (en) * 2008-09-19 2014-02-18 Tandem Diabetes Care, Inc. Solute concentration measurement device and related methods
WO2010037046A1 (en) 2008-09-28 2010-04-01 Fraunhofer Usa, Inc. Humanized neuraminidase antibody and methods of use thereof
US8343498B2 (en) * 2008-10-12 2013-01-01 Massachusetts Institute Of Technology Adjuvant incorporation in immunonanotherapeutics
US8591905B2 (en) 2008-10-12 2013-11-26 The Brigham And Women's Hospital, Inc. Nicotine immunonanotherapeutics
US8343497B2 (en) * 2008-10-12 2013-01-01 The Brigham And Women's Hospital, Inc. Targeting of antigen presenting cells with immunonanotherapeutics
US8277812B2 (en) 2008-10-12 2012-10-02 Massachusetts Institute Of Technology Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
US9974844B2 (en) 2008-11-17 2018-05-22 The Regents Of The University Of Michigan Cancer vaccine compositions and methods of using the same
EP2376619A4 (en) 2008-12-15 2012-07-04 Greenlight Biosciences Inc Methods for control of flux in metabolic pathways
EP2379728A4 (en) * 2008-12-22 2016-04-13 Greenlight Biosciences Inc Compositions and methods for the production of a compound
GB0900930D0 (en) * 2009-01-20 2009-03-04 Future Injection Technologies Ltd Injection device
US9250106B2 (en) 2009-02-27 2016-02-02 Tandem Diabetes Care, Inc. Methods and devices for determination of flow reservoir volume
AU2010217760B2 (en) 2009-02-27 2015-04-09 Tandem Diabetes Care, Inc. Methods and devices for determination of flow reservoir volume
EP2416660B1 (en) 2009-04-07 2014-07-02 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
CA2757622A1 (en) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
JP2012525146A (en) 2009-04-28 2012-10-22 プレジデント アンド フェロウズ オブ ハーバード カレッジ Overcharged protein for cell penetration
US9149465B2 (en) * 2009-05-18 2015-10-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US8765735B2 (en) * 2009-05-18 2014-07-01 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US8927551B2 (en) * 2009-05-18 2015-01-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
JP2012528858A (en) 2009-06-01 2012-11-15 プレジデント アンド フェロウズ オブ ハーバード カレッジ O-GlcNAc transferase inhibitor and use thereof
US9163330B2 (en) 2009-07-13 2015-10-20 President And Fellows Of Harvard College Bifunctional stapled polypeptides and uses thereof
CA2769030C (en) 2009-07-30 2016-05-10 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
GB0913681D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
US9265461B2 (en) 2009-09-01 2016-02-23 Massachusetts Institute Of Technology Identification techniques and device for testing the efficacy of beauty care products and cosmetics
US8758271B2 (en) 2009-09-01 2014-06-24 Massachusetts Institute Of Technology Nonlinear system identification techniques and devices for discovering dynamic and static tissue properties
CA2774973A1 (en) 2009-09-22 2011-03-31 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
EP2483307A1 (en) 2009-09-29 2012-08-08 Fraunhofer USA, Inc. Influenza hemagglutinin antibodies, compositions, and related methods
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US20110143310A1 (en) 2009-12-15 2011-06-16 Hunter Ian W Lorentz-Force Actuated Cleaning Device
AU2010343102B2 (en) 2009-12-29 2016-03-24 Dana-Farber Cancer Institute, Inc. Type II Raf kinase inhibitors
CN102178990B (en) * 2010-01-08 2013-10-09 江苏丞宇米特医疗科技有限公司 Needleless injector
CA2787940C (en) 2010-01-27 2020-01-07 Massachusetts Institute Of Technology Engineered polypeptide agents for targeted broad spectrum influenza neutralization
RU2569061C2 (en) 2010-02-03 2015-11-20 Инфинити Фармасьютикалз, Инк. Inhibitors of amide-hydrolase of fatty acids
JP5827962B2 (en) 2010-03-08 2015-12-02 スローン ケタリング インスティテュート フォア キャンサー リサーチ Cdc7 kinase inhibitors and uses thereof
GB201003920D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
GB201003922D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Conjugation process
US9102697B2 (en) 2010-03-22 2015-08-11 President And Fellows Of Harvard College Trioxacarcins and uses thereof
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
WO2011140296A1 (en) 2010-05-05 2011-11-10 Infinity Pharmaceuticals Triazoles as inhibitors of fatty acid synthase
CA2798330A1 (en) 2010-05-05 2011-11-10 Infinity Pharmaceuticals, Inc. Tetrazolones as inhibitors of fatty acid synthase
CA2797786C (en) 2010-05-07 2020-09-22 Greenlight Biosciences, Inc. Methods for control of flux in metabolic pathways through enzyme relocation
KR101726471B1 (en) 2010-05-11 2017-04-12 랜티우스 메디컬 이메징, 인크. Compositions, methods and systems for the synthesis and use of imaging agents
US9193989B2 (en) 2010-06-18 2015-11-24 Taiho Pharmaceutical Co., Ltd. PRPK-TPRKB modulators and uses thereof
WO2012019168A2 (en) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
DK2603600T3 (en) 2010-08-13 2019-03-04 Aileron Therapeutics Inc PEPTIDOMIMETIC MACROCYCLES
JP6280367B2 (en) 2010-08-31 2018-02-14 グリーンライト バイオサイエンシーズ インコーポレーテッドＧｒｅｅｎｌｉｇｈｔ Ｂｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ． A method for the control of fluxes in metabolic pathways via protease manipulation
WO2012037268A2 (en) 2010-09-15 2012-03-22 Zogenix, Inc. Needle-free injectors and design parameters thereof that optimize injection performance
EP2640405A4 (en) 2010-09-21 2015-04-15 Massachusetts Inst Technology Human-adapted ha polypeptides, vaccines, and influenza treatment
WO2012040459A2 (en) 2010-09-22 2012-03-29 President And Fellows Of Harvard College Beta-catenin targeting peptides and uses thereof
PL3590949T3 (en) 2010-10-01 2022-08-29 Modernatx, Inc. Ribonucleic acids containing n1-methyl-pseudouracils and uses thereof
SG189236A1 (en) 2010-10-04 2013-05-31 Massachusetts Inst Technology Hemagglutinin polypeptides, and reagents and methods relating thereto
JP2013545749A (en) 2010-11-10 2013-12-26 インフィニティー ファーマシューティカルズ， インコーポレイテッド Heterocyclic compounds and uses thereof
MX347708B (en) 2011-01-10 2017-05-09 Infinity Pharmaceuticals Inc Processes for preparing isoquinolinones and solid forms of isoquinolinones.
ES2687494T3 (en) 2011-01-19 2018-10-25 Topokine Therapeutics, Inc. Methods and compositions to reduce body fat
BR112013018920A2 (en) 2011-01-24 2017-11-28 Anterios Inc nanoparticle compositions, formulations thereof and their uses
JP2014503586A (en) 2011-01-24 2014-02-13 アンテリオス， インコーポレイテッド Oil composition
CN109464393A (en) 2011-01-24 2019-03-15 安特里奥公司 Nanoparticulate compositions
EP3510998A1 (en) 2011-03-03 2019-07-17 Tersus Pharmaceuticals, LLC Compositions and methods comprising c16:1n7-palmitoleate
GB201103836D0 (en) 2011-03-07 2011-04-20 Glaxosmithkline Biolog Sa Conjugation process
WO2012135615A2 (en) 2011-03-30 2012-10-04 Brown University Enopeptins, uses thereof, and methods of synthesis thereto
AU2012236099A1 (en) 2011-03-31 2013-10-03 Moderna Therapeutics, Inc. Delivery and formulation of engineered nucleic acids
CA2834834A1 (en) 2011-05-17 2012-11-22 Glaxosmithkline Biologicals S.A. Vaccine against streptococcus pneumoniae
WO2012177997A1 (en) 2011-06-22 2012-12-27 The General Hospital Corporation Treatment of proteinopathies
JP6027610B2 (en) 2011-07-19 2016-11-16 インフィニティー ファーマシューティカルズ， インコーポレイテッド Heterocyclic compounds and uses thereof
CA2842190A1 (en) 2011-07-19 2013-01-24 Infinity Pharmaceuticals Inc. Heterocyclic compounds and uses thereof
DK2734510T3 (en) 2011-07-22 2019-03-04 Massachusetts Inst Technology CLASS I-HISTONDEACETYLASES (HDAC) ACTIVATORS AND APPLICATIONS THEREOF
EP2751093A1 (en) 2011-08-29 2014-07-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US9550000B2 (en) 2011-09-09 2017-01-24 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
JP2014526250A (en) 2011-09-09 2014-10-06 グリーンライト バイオサイエンシーズ インコーポレーテッド Cell-free preparation of carbapenem
EP2755693A4 (en) 2011-09-12 2015-05-20 Moderna Therapeutics Inc Engineered nucleic acids and methods of use thereof
US9630979B2 (en) 2011-09-29 2017-04-25 Infinity Pharmaceuticals, Inc. Inhibitors of monoacylglycerol lipase and methods of their use
RS62993B1 (en) 2011-10-03 2022-03-31 Modernatx Inc Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
MX358886B (en) 2011-10-18 2018-08-31 Aileron Therapeutics Inc Peptidomimetic macrocyles.
US9382239B2 (en) 2011-11-17 2016-07-05 Dana-Farber Cancer Institute, Inc. Inhibitors of c-Jun-N-terminal kinase (JNK)
GB201120000D0 (en) 2011-11-20 2012-01-04 Glaxosmithkline Biolog Sa Vaccine
GB201119999D0 (en) 2011-11-20 2012-01-04 Glaxosmithkline Biolog Sa Vaccine
BR112014014544A2 (en) 2011-12-16 2017-06-13 Univ Florida Uses of 4'-Desferritiocine Analogs
EP4144378A1 (en) 2011-12-16 2023-03-08 ModernaTX, Inc. Modified nucleoside, nucleotide, and nucleic acid compositions
US8426471B1 (en) 2011-12-19 2013-04-23 Topokine Therapeutics, Inc. Methods and compositions for reducing body fat and adipocytes
CA2860711A1 (en) * 2012-01-06 2013-07-11 Svw Technologies Pty Ltd Method and apparatus for castration of animals
AU2013221433B2 (en) 2012-02-15 2018-01-18 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
CN112500466B (en) 2012-02-15 2022-05-03 艾瑞朗医疗公司 Peptidomimetic macrocycles
WO2013151697A1 (en) 2012-04-06 2013-10-10 President And Fellows Of Harvard College Methods and compounds for identifying glycosyltransferase inhibitors
EP2850090B1 (en) 2012-04-06 2018-10-03 President and Fellows of Harvard College Chemoenzymatic methods for synthesizing moenomycin analogs
EP2834254A2 (en) 2012-04-06 2015-02-11 President and Fellows of Harvard College Moenomycin analogs, methods of synthesis, and uses thereof
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
WO2013163088A1 (en) 2012-04-23 2013-10-31 Zogenix, Inc. Piston closures for drug delivery capsules
US9597385B2 (en) 2012-04-23 2017-03-21 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
WO2013169377A1 (en) 2012-05-10 2013-11-14 Massachusetts Institute Of Technology Agents for influenza neutralization
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
CA2879939A1 (en) 2012-08-06 2014-02-13 Glaxosmithkline Biologicals S.A. Novel method
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
CA2880701A1 (en) 2012-08-18 2014-02-27 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
CA2925035C (en) 2012-09-26 2021-05-25 President And Fellows Of Harvard College Proline-locked stapled peptides and uses thereof
US20150225471A1 (en) 2012-10-01 2015-08-13 President And Fellows Of Harvard College Stabilized polypeptide insulin receptor modulators
LT2909204T (en) 2012-10-12 2019-05-10 The Broad Institute, Inc. Gsk3 inhibitors and methods of use thereof
US10112927B2 (en) 2012-10-18 2018-10-30 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinase 7 (CDK7)
USRE48175E1 (en) 2012-10-19 2020-08-25 Dana-Farber Cancer Institute, Inc. Hydrophobically tagged small molecules as inducers of protein degradation
WO2014063054A1 (en) 2012-10-19 2014-04-24 Dana-Farber Cancer Institute, Inc. Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof
BR112015009470A2 (en) 2012-11-01 2019-12-17 Aileron Therapeutics Inc disubstituted amino acids and their methods of preparation and use
RS58023B2 (en) 2012-11-01 2021-12-31 Infinity Pharmaceuticals Inc Treatment of cancers using pi3 kinase isoform modulators
WO2014071247A1 (en) 2012-11-02 2014-05-08 Dana-Farber Cancer Institute, Inc. Pyrrol-1 -yl benzoic acid derivates useful as myc inhibitors
EP2922542A4 (en) 2012-11-21 2016-10-05 Topokine Therapeutics Inc Methods and compositions for locally increasing body fat
WO2014082065A1 (en) 2012-11-26 2014-05-30 President And Fellows Of Harvard College Trioxacarcins, trioxacarcin-antibody conjugates, and uses thereof
SI2922554T1 (en) 2012-11-26 2022-06-30 Modernatx, Inc. Terminally modified rna
WO2014100695A1 (en) 2012-12-21 2014-06-26 Epizyme, Inc. Prmt5 inhibitors and uses thereof
UA118548C2 (en) 2012-12-21 2019-02-11 Епізайм, Інк. Teatrahydro- and dihydro-isoquinoline prmt5 inhibitors and uses thereof
CA2894130A1 (en) 2012-12-21 2014-06-26 Epizyme, Inc. Prmt5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
WO2014100716A1 (en) 2012-12-21 2014-06-26 Epizyme, Inc. Prmt5 inhibitors and uses thereof
EP3434774A1 (en) 2013-01-17 2019-01-30 ModernaTX, Inc. Signal-sensor polynucleotides for the alteration of cellular phenotypes
WO2014124319A2 (en) 2013-02-07 2014-08-14 Massachusetts Institute Of Technology Human adaptation of h5 influenza
CA2900008A1 (en) 2013-02-07 2014-08-14 Children's Medical Center Corporation Protein antigens that provide protection against pneumococcal colonization and/or disease
CN115804749A (en) 2013-03-11 2023-03-17 度瑞公司 Injectable controlled release compositions comprising high viscosity liquid carriers
WO2014159813A1 (en) 2013-03-13 2014-10-02 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
BR112015022872A2 (en) 2013-03-13 2017-11-07 Harvard College stapled and stitched polypeptides, their use, their method of preparation, their composition and amino acid
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
US20160024051A1 (en) 2013-03-15 2016-01-28 Infinity Pharmaceuticals, Inc. Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
CA2907915C (en) 2013-04-03 2023-03-07 Allertein Therapeutics, Llc Immunomodulatory nanoparticle compositions comprising a plurality of nanoparticles comprising biodegradable or biocompatible polymers and hydrophilic and hydrophobic cellular components
WO2014165792A2 (en) 2013-04-04 2014-10-09 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
ES2774330T3 (en) 2013-04-09 2020-07-20 Massachusetts Inst Technology Drug supply polymer and uses thereof
US10301359B2 (en) 2013-04-30 2019-05-28 Massachusetts Institute Of Technology Human adaptation of H3 influenza
US9315472B2 (en) 2013-05-01 2016-04-19 Massachusetts Institute Of Technology 1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
NO2753788T3 (en) 2013-05-10 2018-06-16
EP3003309B1 (en) 2013-05-30 2020-09-09 Infinity Pharmaceuticals, Inc. Treatment of cancers using pi3 kinase isoform modulators
WO2014197723A2 (en) 2013-06-05 2014-12-11 Massachusetts Institute Of Technology Human adaptation of h7 ha
AU2014278231B2 (en) 2013-06-11 2017-05-25 KALA BIO, Inc. Urea derivatives and uses thereof
US10227390B2 (en) 2013-06-14 2019-03-12 President And Fellows Of Harvard College Stabilized polypeptide insulin receptor modulators
EP3013365B1 (en) 2013-06-26 2019-06-05 Academia Sinica Rm2 antigens and use thereof
WO2014210564A1 (en) 2013-06-27 2014-12-31 Academia Sinica Glycan conjugates and use thereof
RU2016105108A (en) 2013-07-25 2017-08-30 Дана-Фарбер Кэнсер Инститьют, Инк. TRANSCRIPTION FACTOR INHIBITORS AND THEIR APPLICATION
CN105658807A (en) 2013-08-05 2016-06-08 绿光生物科技股份有限公司 Engineered proteins with protease cleavage site
AU2014304545A1 (en) 2013-08-05 2016-02-25 Glaxosmithkline Biologicals S.A. Combination immunogenic compositions
US9782476B2 (en) 2013-09-06 2017-10-10 Academia Sinica Human iNKT cell activation using glycolipids with altered glycosyl groups
PE20160685A1 (en) 2013-10-04 2016-07-23 Infinity Pharmaceuticals Inc HETEROCYCLIC COMPOUNDS AND USES OF THEM
WO2015051241A1 (en) 2013-10-04 2015-04-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US9982009B2 (en) 2013-10-15 2018-05-29 Massachusetts Institute Of Technology Methods for treating polycystic kidney disease and polycystic liver disease
WO2015057958A2 (en) 2013-10-16 2015-04-23 Massachusetts Institute Of Technology Enterobactin conjugates and uses thereof
US10047070B2 (en) 2013-10-18 2018-08-14 Dana-Farber Cancer Institute, Inc. Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)
AU2014337122B2 (en) 2013-10-18 2019-01-03 Dana-Farber Cancer Institute, Inc. Heteroaromatic compounds useful for the treatment of proliferative diseases
WO2015061204A1 (en) 2013-10-21 2015-04-30 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CN106061261B (en) 2013-11-01 2018-04-24 卡拉制药公司 Crystal form of therapeutic compounds and application thereof
JP6494631B2 (en) 2013-12-24 2019-04-03 プレジデント アンド フェローズ オブ ハーバード カレッジ Colchistatin analogues and their synthesis and use
WO2015109180A2 (en) 2014-01-16 2015-07-23 Academia Sinica Compositions and methods for treatment and detection of cancers
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
MX2016008549A (en) 2014-01-27 2016-09-26 Te Pari Products Ltd A fluid dispenser.
US10793571B2 (en) 2014-01-31 2020-10-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
AU2015226911B2 (en) 2014-03-07 2018-03-01 The Arizona Board Of Regents On Behalf Of The University Of Arizona Non-narcotic CRMP2 peptides targeting sodium channels for chronic pain
MX2016012021A (en) 2014-03-19 2017-04-13 Infinity Pharmaceuticals Inc Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders.
CN106415244B (en) 2014-03-27 2020-04-24 中央研究院 Reactive marker compounds and uses thereof
JP6836400B2 (en) 2014-03-28 2021-03-03 ユニバーシティ オブ ワシントン スルー イッツ センター フォー コマーシャリゼーション Breast and ovarian cancer vaccines
US9862688B2 (en) 2014-04-23 2018-01-09 Dana-Farber Cancer Institute, Inc. Hydrophobically tagged janus kinase inhibitors and uses thereof
US10017477B2 (en) 2014-04-23 2018-07-10 Dana-Farber Cancer Institute, Inc. Janus kinase inhibitors and uses thereof
WO2015168079A1 (en) 2014-04-29 2015-11-05 Infinity Pharmaceuticals, Inc. Pyrimidine or pyridine derivatives useful as pi3k inhibitors
US10039816B2 (en) 2014-04-30 2018-08-07 Massachusetts Institute Of Technology Siderophore-based immunization against gram-negative bacteria
CN114805527A (en) 2014-05-21 2022-07-29 哈佛大学的校长及成员们 RAS inhibitory peptides and uses thereof
JP6894239B2 (en) 2014-05-27 2021-06-30 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ Compositions and methods for universal glycoforms for enhanced antibody efficacy
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
CA2950415A1 (en) 2014-05-27 2015-12-03 Academia Sinica Anti-cd20 glycoantibodies and uses thereof
CA2950440A1 (en) 2014-05-27 2015-12-03 Academia Sinica Anti-her2 glycoantibodies and uses thereof
TWI732738B (en) 2014-05-28 2021-07-11 中央研究院 Anti-tnf-alpha glycoantibodies and uses thereof
JP6664338B2 (en) 2014-06-13 2020-03-13 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム Immunogenic combination
MA40240B1 (en) 2014-06-19 2019-03-29 Ariad Pharma Inc Heteroaryl compounds of kinase inhibition
WO2015200425A1 (en) 2014-06-27 2015-12-30 Topokine Therapeutics, Inc. Topical dosage regimen
EP3164379A1 (en) 2014-07-02 2017-05-10 Massachusetts Institute of Technology Polyamine-fatty acid derived lipidoids and uses thereof
EP3169699A4 (en) 2014-07-18 2018-06-20 The University of Washington Cancer vaccine compositions and methods of use thereof
US10736966B2 (en) 2014-08-12 2020-08-11 Massachusetts Institute Of Technology Brush-poly (glycoamidoamine)-lipids and uses thereof
WO2016040369A2 (en) 2014-09-08 2016-03-17 Academia Sinica HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
SG10201902598VA (en) 2014-09-24 2019-04-29 Aileron Therapeutics Inc Peptidomimetic macrocycles and formulations thereof
CN112245565A (en) 2014-09-24 2021-01-22 艾瑞朗医疗公司 Peptidomimetic macrocycles and uses thereof
US9708348B2 (en) 2014-10-03 2017-07-18 Infinity Pharmaceuticals, Inc. Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
KR20210142781A (en) 2014-10-21 2021-11-25 다케다 야쿠힌 고교 가부시키가이샤 Crystalline forms of 5-chloro-n4-[2-(dimethylphosphoryl)phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]pyrimidine-2,4-diamine
US20180015101A1 (en) 2014-10-28 2018-01-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions and methods for antigen-specific tolerance
EP3461904A1 (en) 2014-11-10 2019-04-03 ModernaTX, Inc. Alternative nucleic acid molecules containing reduced uracil content and uses thereof
WO2016086026A1 (en) 2014-11-26 2016-06-02 Kala Pharmaceuticals, Inc. Crystalline forms of a therapeutic compound and uses thereof
EP3230272B1 (en) 2014-12-10 2020-08-19 Kala Pharmaceuticals, Inc. 1-amino-triazolo(1,5-a)pyridine-substituted urea derivative and uses thereof
EP3037119A1 (en) * 2014-12-23 2016-06-29 Hipra Scientific, S.L.U. Device for administering medicinal products
EP3237066B1 (en) 2014-12-23 2020-10-21 Sloan-Kettering Institute for Cancer Research Polymorph of granaticin b
WO2016105528A2 (en) 2014-12-23 2016-06-30 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinase 7 (cdk7)
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
WO2016118191A1 (en) 2015-01-24 2016-07-28 Academia Sinica Novel glycan conjugates and methods of use thereof
SG11201707750YA (en) 2015-03-20 2017-10-30 Aileron Therapeutics Inc Peptidomimetic macrocycles and uses thereof
WO2016160617A2 (en) 2015-03-27 2016-10-06 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinases
CA2980172A1 (en) 2015-03-30 2016-10-06 Greenlight Biosciences, Inc. Cell-free production of ribonucleic acid
US10570104B2 (en) 2015-04-27 2020-02-25 University Of Florida Research Foundation, Incorporated Metabolically programmed metal chelators and uses thereof
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
US10702527B2 (en) 2015-06-12 2020-07-07 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
CN107848988B (en) 2015-06-19 2021-10-22 麻省理工学院 Alkenyl substituted 2, 5-piperazinediones and their use in compositions for delivering an agent to a subject or cell
WO2017004548A1 (en) 2015-07-01 2017-01-05 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
EP3347018B1 (en) 2015-09-09 2021-09-01 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinases
JP2018528217A (en) 2015-09-10 2018-09-27 エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． Peptidomimetic macrocycles as modulators of MCL-1
DK3350333T3 (en) 2015-09-17 2022-01-31 Modernatx Inc POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION
ES2910425T3 (en) 2015-09-17 2022-05-12 Modernatx Inc Compounds and compositions for the intracellular delivery of therapeutic agents
EP3355882A1 (en) 2015-10-01 2018-08-08 Kythera Biopharmaceuticals, Inc. Compositions comprising a statin for use in methods of adipolysis
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
SI3394030T1 (en) 2015-12-22 2022-04-29 Modernatx, Inc. Compounds and compositions for intracellular delivery of agents
JP2019515876A (en) 2016-03-08 2019-06-13 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ Methods for module synthesis of N-glycans and their arrays
US10759806B2 (en) 2016-03-17 2020-09-01 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
WO2017176963A1 (en) 2016-04-06 2017-10-12 Greenlight Biosciences, Inc. Cell-free production of ribonucleic acid
MX2018014887A (en) 2016-06-03 2019-06-06 Sanofi Pasteur Inc Modification of engineered influenza hemagglutinin polypeptides.
US10105449B2 (en) 2016-06-07 2018-10-23 Massachusetts Institute Of Technology Drug delivery polymers and uses thereof
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
JP2019525901A (en) 2016-06-14 2019-09-12 モデルナティエックス インコーポレイテッドＭｏｄｅｒｎａＴＸ，Ｉｎｃ． Stabilized preparation of lipid nanoparticles
GB201610599D0 (en) 2016-06-17 2016-08-03 Glaxosmithkline Biologicals Sa Immunogenic Composition
KR102467074B1 (en) 2016-08-05 2022-11-11 사노피 파스퇴르 인코포레이티드 Polyvalent pneumococcal polysaccharide-protein conjugate composition
BR112019001971A2 (en) 2016-08-05 2019-05-07 Sanofi Pasteur, Inc. multivalent pneumococcal polysaccharide-protein conjugate composition
AU2017316663B2 (en) 2016-08-22 2024-02-22 CHO Pharma Inc. Antibodies, binding fragments, and methods of use
CN106345010B (en) * 2016-08-24 2019-08-23 吉林省农业科学院 A kind of animal injection device with store function
SG10201609111WA (en) 2016-10-31 2018-05-30 Miracle Man Pte Ltd Safety-Enhanced Needle-Free Injector And System For Use Through Both Porous And Non-Porous Materials
JP6801381B2 (en) * 2016-11-07 2020-12-16 東ソー株式会社 Freeze-dried sample pretreatment reagent
WO2018089540A1 (en) 2016-11-08 2018-05-17 Modernatx, Inc. Stabilized formulations of lipid nanoparticles
WO2018106738A1 (en) 2016-12-05 2018-06-14 Massachusetts Institute Of Technology Brush-arm star polymers, conjugates and particles, and uses thereof
DE102017102765A1 (en) 2017-02-13 2018-08-16 Rudolf Götz Kit-of-Parts
WO2018170306A1 (en) 2017-03-15 2018-09-20 Modernatx, Inc. Compounds and compositions for intracellular delivery of therapeutic agents
US20200129445A1 (en) 2017-03-15 2020-04-30 Modernatx, Inc. Lipid nanoparticle formulation
US11555031B2 (en) 2017-03-20 2023-01-17 The Broad Institute, Inc. Compounds and methods for regulating insulin secretion
BR112019020810A2 (en) 2017-04-05 2020-04-28 Biogen Ma Inc tricyclic compounds as glycogen synthase kinase 3 (gsk3) inhibitors and uses thereof
EP3638678A1 (en) 2017-06-14 2020-04-22 Modernatx, Inc. Compounds and compositions for intracellular delivery of agents
CN107252512B (en) * 2017-06-16 2018-03-13 南阳市中心医院 A kind of gas-driven needle-less syringe
EP4327876A2 (en) 2017-06-23 2024-02-28 Affinivax, Inc. Immunogenic compositions
WO2019013790A1 (en) 2017-07-12 2019-01-17 Curza Global, Llc Antimicrobial compounds and uses thereof
WO2019013789A1 (en) 2017-07-12 2019-01-17 Curza Global, Llc Antimicrobial compounds
CA3073211A1 (en) 2017-08-31 2019-03-07 Modernatx, Inc. Methods of making lipid nanoparticles
AU2018347405B2 (en) 2017-10-11 2022-02-03 Greenlight Biosciences, Inc. Methods and compositions for nucleoside triphosphate and ribonucleic acid production
US11786477B2 (en) 2017-12-01 2023-10-17 North Carolina State University Fibrin particles and methods of making the same
GB201721576D0 (en) 2017-12-21 2018-02-07 Glaxosmithkline Biologicals Sa Hla antigens and glycoconjugates thereof
GB201721582D0 (en) 2017-12-21 2018-02-07 Glaxosmithkline Biologicals Sa S aureus antigens and immunogenic compositions
DE102018107103A1 (en) * 2018-03-26 2019-09-26 Henke-Sass, Wolf Gmbh Device for applying a fluid
DE102018107102A1 (en) * 2018-03-26 2019-09-26 Henke-Sass, Wolf Gmbh Device for applying a fluid
DE102018107101A1 (en) * 2018-03-26 2019-09-26 Henke-Sass, Wolf Gmbh Device for applying a fluid
EP3853202A1 (en) 2018-09-19 2021-07-28 ModernaTX, Inc. Compounds and compositions for intracellular delivery of therapeutic agents
CN113271926A (en) 2018-09-20 2021-08-17 摩登纳特斯有限公司 Preparation of lipid nanoparticles and methods of administration thereof
US10953213B2 (en) * 2018-10-22 2021-03-23 Carson B. Vester Tattoo device
EP3911644A1 (en) 2019-01-16 2021-11-24 Curza Global LLC Antimicrobial compounds and methods
AU2020209167A1 (en) 2019-01-16 2021-08-12 Curza Global, Llc Antimicrobial compounds and methods
CA3128215A1 (en) 2019-01-31 2020-08-06 Modernatx, Inc. Methods of preparing lipid nanoparticles
WO2020168466A1 (en) 2019-02-19 2020-08-27 Stemirna Therapeutics Co., Ltd. Modified nucleoside and synthetic methods thereof
JP2022527712A (en) * 2019-03-29 2022-06-03 アイジェックス・ファーマインターナショナル株式会社 Needleless syringe and related methods
WO2021022173A1 (en) 2019-07-31 2021-02-04 Modernatx, Inc. Compositions and methods for delivery of rna interference agents to immune cells
US20220265803A1 (en) 2019-07-31 2022-08-25 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
DE102019123734A1 (en) * 2019-09-04 2021-03-04 Henke-Sass, Wolf Gmbh Device for applying a fluid
DE102019123737A1 (en) * 2019-09-04 2021-03-04 Henke-Sass, Wolf Gmbh Device for applying a fluid
DE102019123733A1 (en) * 2019-09-04 2021-03-04 Henke-Sass, Wolf Gmbh Device for applying a fluid
DE102019123731A1 (en) * 2019-09-04 2021-03-04 Henke-Sass, Wolf Gmbh Device for applying a fluid
DE102019123732A1 (en) * 2019-09-04 2021-03-04 Henke-Sass, Wolf Gmbh Device for applying a fluid
CN115297930A (en) 2019-11-13 2022-11-04 库扎环球有限责任公司 Antimicrobial compounds and methods
KR102518758B1 (en) * 2020-01-21 2023-04-06 미라클스코프(주) Needleless injector
CA3169669A1 (en) 2020-01-31 2021-08-05 Modernatx, Inc. Methods of preparing lipid nanoparticles
WO2021173965A1 (en) 2020-02-28 2021-09-02 Massachusetts Institute Of Technology Identification of variable influenza residues and uses thereof
RU200703U1 (en) * 2020-03-20 2020-11-06 Общество с ограниченной ответственностью "АТ-ЛИРТ" LIQUID PUMP FOR CHEMILUMINESCENT MEASUREMENTS FROM AIRCRAFT
WO2021231729A1 (en) 2020-05-13 2021-11-18 Sanofi Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza
KR102427261B1 (en) * 2020-06-15 2022-08-02 유수옥 Injector
DE102020119751A1 (en) 2020-07-27 2022-01-27 Henke-Sass, Wolf Gmbh Device for applying a fluid
EP4238567A1 (en) 2020-10-30 2023-09-06 Keio University Novel treatment and prevention of sarcopenia-related diseases
EP4238979A1 (en) 2020-10-30 2023-09-06 Xeno-Interface Inc. Beta-strand type crosslinked peptide
AR124267A1 (en) 2020-12-09 2023-03-01 Genentech Inc HIGH THROUGH METHODS FOR PREPARING LIPID NANOPARTICLES AND THEIR USES
EP4305088A1 (en) 2021-03-09 2024-01-17 Massachusetts Institute of Technology Branched poly(-amino esters) for the delivery of nucleic acids
TW202313065A (en) 2021-05-28 2023-04-01 美商季卡尼醫療公司 Compounds for treating genetic diseases
WO2023018817A1 (en) 2021-08-11 2023-02-16 Sanofi Pasteur Inc. Truncated influenza neuraminidase and methods of using the same
US20230233667A1 (en) 2021-09-08 2023-07-27 Affinivax, Inc. Coronavirus vaccine
CA3233926A1 (en) 2021-10-08 2023-04-13 Sanofi Pasteur Inc. Multivalent influenza vaccines
WO2023081798A1 (en) 2021-11-05 2023-05-11 Sanofi Pasteur Inc. Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of using the same
WO2023079113A1 (en) 2021-11-05 2023-05-11 Sanofi Hybrid multivalent influenza vaccines comprising hemagglutinin and neuraminidase and methods of using the same
WO2023114889A1 (en) 2021-12-16 2023-06-22 Modernatx, Inc. Processes for preparing lipid nanoparticles
WO2023129963A1 (en) 2021-12-30 2023-07-06 Curza Global, Llc Antimicrobial compounds and methods
WO2023144206A1 (en) 2022-01-27 2023-08-03 Sanofi Pasteur Modified vero cells and methods of using the same for virus production
WO2023177579A1 (en) 2022-03-14 2023-09-21 Sanofi Pasteur Inc. Machine-learning techniques in protein design for vaccine generation
WO2023193002A1 (en) 2022-04-01 2023-10-05 Modernatx, Inc. Cross mixers for lipid nanoparticle production, and methods of operating the same
WO2023235380A1 (en) 2022-06-01 2023-12-07 Zikani Therapeutics, Inc. Macrolides for treating genetic diseases
WO2023250513A1 (en) 2022-06-24 2023-12-28 Zikani Therapeutics, Inc. 13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
WO2024026487A1 (en) 2022-07-29 2024-02-01 Modernatx, Inc. Lipid nanoparticle compositions comprising phospholipid derivatives and related uses
WO2024026482A1 (en) 2022-07-29 2024-02-01 Modernatx, Inc. Lipid nanoparticle compositions comprising surface lipid derivatives and related uses
WO2024026475A1 (en) 2022-07-29 2024-02-01 Modernatx, Inc. Compositions for delivery to hematopoietic stem and progenitor cells (hspcs) and related uses
WO2024049994A1 (en) 2022-09-01 2024-03-07 Zikani Therapeutics, Inc. Treatment of familial adenomatous polyopsis using a 13-membered macrolide

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1052043A (en) *
US2398544A (en) * 1945-01-06 1946-04-16 Marshall L Lockhart Hypodermic injector
FR1049564A (en) * 1951-11-22 1953-12-30 Normeca Advanced injection syringe
US2762369A (en) * 1954-09-07 1956-09-11 Scherer Corp R P Hypodermic injector with adjustable impact plunger
DK87314C (en) * 1954-10-27 1959-05-19 Astra Apotekarnes Kem Fab Syringe.
GB805184A (en) * 1957-01-29 1958-12-03 Becton Dickinson Co Hypodermic assembly
US2928390A (en) * 1957-07-15 1960-03-15 Scherer Corp R P Multi-dose hypodermic injector
GB915262A (en) * 1957-11-01 1963-01-09 Secr Aviation Improvements in/or relating to hypodermic injection apparatus
CH393640A (en) * 1960-06-10 1965-06-15 Int Treuhand Ag Injection ampoule
GB993309A (en) * 1961-04-11 1965-05-26 Express Injector Company Ltd Improved hypodermic injector
GB971162A (en) * 1961-11-21 1964-09-30 British Oxygen Co Ltd Injection inoculation instruments
US3330276A (en) * 1963-10-07 1967-07-11 Scherer Corp R P Hypodermic jet injector
US3526225A (en) * 1967-03-31 1970-09-01 Tokyo Sokuhan Kk Jet-type hypodermic injection device
BE755224A (en) * 1969-08-25 1971-02-24 Philips Nv INJECTION SYRINGE
BE795162A (en) * 1972-02-10 1973-08-08 Philips Nv INJEKTIE-INRICHTING
US3802430A (en) * 1972-06-30 1974-04-09 L Arnold Disposable pyrotechnically powered injector
US3859996A (en) * 1973-07-18 1975-01-14 Mizzy Inc Multi-dose injector
US3882863A (en) * 1973-08-01 1975-05-13 Survival Technology Hypodermic injection device having cannula covered with resilient sheath
JPS51130094A (en) * 1975-05-08 1976-11-12 Asahi Chemical Ind Twoostage pressure injector
US4031893A (en) * 1976-05-14 1977-06-28 Survival Technology, Inc. Hypodermic injection device having means for varying the medicament capacity thereof
US4089334A (en) * 1976-10-07 1978-05-16 Schwebel Paul R Pyrotechnically powered needleless injector
SU718111A1 (en) * 1978-07-12 1980-02-29 Предприятие П/Я А-3556 Needleless injector
ATE9546T1 (en) * 1980-02-19 1984-10-15 Stephen Clark Wardlaw HYPODERMATIC SYRINGES.
US4329988A (en) * 1980-12-23 1982-05-18 Survival Technology, Inc. Plural injection assembly
US4421508A (en) * 1981-02-24 1983-12-20 Cohen Edgar C Vacuum-compression injector
DE3278101D1 (en) * 1981-08-10 1988-03-17 Duphar Int Res Automatic injection syringe
EP0107874B1 (en) * 1982-10-27 1986-11-26 Duphar International Research B.V Automatic injection device
FR2539302B1 (en) * 1983-01-17 1986-03-14 Brunet Jean Louis SYRINGE FOR MEDICAL USE
DE3342407A1 (en) * 1983-11-24 1985-06-05 Erwin 6950 Mosbach Maurer INJECTION DEVICE
US4578064A (en) * 1983-12-21 1986-03-25 Survival Technology Inc. Plural dosage automatic injector with improved safety
US4484910A (en) * 1983-12-21 1984-11-27 Survival Technology, Inc. Dual mode automatic injector
FR2567760A1 (en) * 1984-07-18 1986-01-24 Hibon Joseph APPARATUS FOR EXECUTING SERIES OF DRUG INJECTIONS
DE3427189A1 (en) * 1984-07-24 1986-02-20 Hoechst Ag, 6230 Frankfurt LOCKING FOR THE DETACHABLE VACCINE PUMP OF A NEEDLE-FREE INJECTION DEVICE
BR8404286A (en) * 1984-08-28 1986-04-08 Sergio Landau PRESSURE HYPODERMIC SYRINGE
DE3566866D1 (en) * 1984-11-02 1989-01-26 Duphar Int Res Automatic injection device
US4596556A (en) * 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
ATE55260T1 (en) * 1985-10-11 1990-08-15 Duphar Int Res AUTOMATIC SYRINGE.
EP0245895B1 (en) * 1986-05-15 1991-09-18 Duphar International Research B.V Automatic injector
FR2609400A2 (en) * 1986-06-16 1988-07-15 Michel Pistor THERAPEUTIC, PORTABLE, TOTALLY AUTONOMOUS, TRANSDERMIC DEVICE HAVING MEANS FOR INTRODUCING AN AGENT WITH THERAPEUTIC ACTIVITY IN A TANK OF THE DEVICE AT ANY TIME
US4722728A (en) * 1987-01-23 1988-02-02 Patents Unlimited, Ltd. Needleless hypodermic injector
US4850968A (en) * 1987-07-27 1989-07-25 Ar.Ma.S.R.L. Self-blocking hypodermic syringe for once-only use, comprising a needle protection cap
JPH01198561A (en) * 1987-11-16 1989-08-10 Medhi Tek Internatl Ltd Liquid injection apparatus
US4874367A (en) * 1988-02-05 1989-10-17 Marpam International, Inc. Hypodermic jet injector and cartridge therefor
US4913699A (en) * 1988-03-14 1990-04-03 Parsons James S Disposable needleless injection system
BR8801952A (en) * 1988-04-22 1989-11-14 Sergio Landau DISPOSABLE CAPSULE, NOT RE-USABLE, CONTAINING INDIVIDUAL DOSE OF VACCINE TO BE HYPODERMICALLY INJECTED, WITHOUT NEEDLE, WITH PRESSURE INJECTOR
JPH0284962A (en) * 1988-06-14 1990-03-26 Vci Corp Negative pressure press contact needle free syringe
US4894054A (en) * 1988-06-20 1990-01-16 Miskinyar Shir A Preloaded automatic disposable syringe
GB8819977D0 (en) * 1988-08-23 1988-09-21 Medimech Ltd Automatic injectors
DE8813905U1 (en) * 1988-11-07 1989-12-07 Nothdurft, Klaus, 7000 Stuttgart, De
DE8813938U1 (en) * 1988-11-08 1989-12-07 Nothdurft, Klaus, 7000 Stuttgart, De
EP0405320A3 (en) * 1989-06-27 1991-04-03 Elkom - Tovarna Stikalnih Naprav Multipurpose automatic injector
US5085641A (en) * 1989-07-17 1992-02-04 Survival Technology, Inc. Conveniently carried frequent use auto-injector with improved cap structure
US5102393A (en) * 1989-07-17 1992-04-07 Survival Technology, Inc. Autoinjector converted from intramuscular to subcutaneous mode of injection
FR2651314A1 (en) * 1989-08-25 1991-03-01 Taddei Andre PORTABLE DEVICE FOR PERFORMING MULTIPLE ASSAYS OF A LIQUID OR PASTY PRODUCT.
AU6550990A (en) * 1989-11-09 1991-05-16 Bioject, Inc. Needleless hypodermic injection device
WO1991012839A1 (en) * 1990-03-02 1991-09-05 Igor Alexandrovich Khanin Needle-jet injector for introducing medical preparations into an internal organ of a patient
DE4008068A1 (en) * 1990-03-14 1991-09-19 Pfeiffer Erich Gmbh & Co Kg DISCHARGE DEVICE FOR MEDIA
US5092843A (en) * 1990-04-12 1992-03-03 Survival Technology, Inc. Dispersion multichamber auto-injector
DE9005419U1 (en) * 1990-05-12 1990-07-19 Nothdurft, Klaus, 7000 Stuttgart, De
WO1992008508A1 (en) * 1990-11-09 1992-05-29 Sy-Quest International Limited Needleless hypodermic jet injector device
GB9100819D0 (en) * 1991-01-15 1991-02-27 Medimech Int Ltd Subcutaneous injector
FR2671729A1 (en) * 1991-01-17 1992-07-24 Micro Dose Pharma DEVICE FOR DELIVERING CONTROLLED DOSES, PARTICULARLY OF THE DISPOSABLE INSULIN SYRINGE TYPE.
US5176643A (en) * 1991-04-29 1993-01-05 George C. Kramer System and method for rapid vascular drug delivery
WO1992020388A1 (en) * 1991-05-13 1992-11-26 Sti International Limited Automatic injectors
GB9111600D0 (en) * 1991-05-30 1991-07-24 Owen Mumford Ltd Improvements relating to injection devices
EP0518416A1 (en) * 1991-06-13 1992-12-16 Duphar International Research B.V Injection device
DE4120267A1 (en) * 1991-06-19 1992-12-24 Bader & Partner Medizintechnik METHOD FOR OPERATING A DEVICE FOR DELIVERING A LIQUID MEDICAL TREATMENT SUBSTANCE TO A BODY TO BE TREATED, AND DEVICE FOR IMPLEMENTING THE METHOD
EP0525525B1 (en) * 1991-07-24 1995-05-03 Medico Development Investment Company Injector
WO1993013819A1 (en) * 1992-01-07 1993-07-22 Sti International Limited Automatic injectors
DE69302852T2 (en) * 1992-03-27 1996-09-26 Duphar Int Res Automatic syringe
IL105706A (en) * 1992-05-15 1996-10-16 Safe T Ltd Hollow needle applicator
US5334144A (en) * 1992-10-30 1994-08-02 Becton, Dickinson And Company Single use disposable needleless injector

Also Published As

Publication number Publication date
EP0599940A1 (en) 1994-06-08
KR100233339B1 (en) 1999-12-01
RU2129445C1 (en) 1999-04-27
DE69223793T2 (en) 1998-04-23
JP3257794B2 (en) 2002-02-18
NO307817B1 (en) 2000-06-05
US5480381A (en) 1996-01-02
WO1993003779A1 (en) 1993-03-04
AU2444592A (en) 1993-03-16
RU94028893A (en) 1996-06-10
ATE161427T1 (en) 1998-01-15
JPH06509954A (en) 1994-11-10
JP3257795B2 (en) 2002-02-18
NO940606L (en) 1994-04-21
EP0599940B1 (en) 1997-12-29
CA2116341C (en) 1999-12-14
NO940606D0 (en) 1994-02-22
DE69223793D1 (en) 1998-02-05
JPH07500417A (en) 1995-01-12
ES2110513T3 (en) 1998-02-16
BR9206407A (en) 1994-12-13
GB9118204D0 (en) 1991-10-09
HK1010993A1 (en) 1999-07-02

Similar Documents

Publication Publication Date Title
CA2116341A1 (en) Needleless Injector
ES8404777A1 (en) Needleless jet injector
EP0711571A4 (en) Injector type atomizer
CA2209534A1 (en) Prefilled syringe for medical use
CA2171632A1 (en) Improvement in injection cartridges
CA2218734A1 (en) Dual action syringe
CA2162909A1 (en) Syringe for infusion
AU6061094A (en) Mixing capsule for dental compositions
CA2232151A1 (en) Device of miniaturised construction for producing high pressure in a fluid to be atomised
WO2003011372A3 (en) Reservoir module with a piston rod
EP0340899A3 (en) Syringe
EP1097727A3 (en) Needleless injector drug capsule and adaptor for filling the same
SE9302121D0 (en) APPARATUS FOR CONTROLLED DELIVERY OF LIQUIDS
CA2139733A1 (en) Multidirectional trigger sprayer dispenser
EP0363338A3 (en) Dosing/mixing syringe
WO1988002640A3 (en) Improvements in or relating to syringes
CA2083975A1 (en) Miniature pump dispenser
CA2122445A1 (en) A method and device for dosing a liquid preparation
CA2060178A1 (en) Fluid discharge apparatus
JPS57139216A (en) Liquid injection equipment
CA2082159A1 (en) Injection device
IL125110A0 (en) Lignosulfonate-based dispersant and its use in solid phytosanitary formulations
JPS6445876A (en) Production of size for spray sizing
TW340036B (en) Method of dispensing reproducible amounts of an aerated deformable composition
FR2377536A1 (en) System generating high shock pressure in liq. - has shouldered piston in compressed air cylinder and extension valve to improve acceleration

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed